News

Elieen, Actual Sientra Patient

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Sientra Reports Record Third Quarter 2021 Revenue for Continuing Operations November 10, 2021
Sientra to Participate in Upcoming Investor Conferences November 1, 2021
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) October 28, 2021
Sientra to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021 October 27, 2021
Sientra® And Mission Plasticos Launch Reshaping Lives: Full Circle™ A Philanthropic Initiative For Women Living In Poverty In America October 19, 2021
New Study Confirms Sientra’s AlloX2’s Unique Value in Managing Seroma and Infection Post Reconstruction Procedures August 25, 2021
Sientra Reports Record Breast Products Revenue for Second Quarter 2021, Raises Revenue Guidance for Full Year 2021 August 10, 2021
Sientra to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021 July 27, 2021
Sientra Appoints Two Medical Aesthetics Leaders to its Board of Directors July 19, 2021
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) July 16, 2021
Sientra Announces Appointment of Chief Financial Officer July 12, 2021
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 29, 2021
Sientra Announces Closing of Previously Announced Sale of miraDry Business to 1315 Capital June 11, 2021
Sientra Announces Addition of Vice President of Research & Development June 1, 2021
Sientra to Participate in Upcoming Virtual Investor Conferences May 18, 2021
Sientra Reports Record First Quarter 2021 Financial Results May 11, 2021
Sientra Announces Sale of miraDry Business to 1315 Capital May 11, 2021
Sientra Receives Innovative Technology Contract from Vizient for AlloX2® Tissue Expander May 5, 2021
Sientra and Butterfly Network Announce Strategic Partnership to Improve Diagnostic Surveillance of Breast Implant Patients April 30, 2021
Sientra to Report First Quarter 2021 Financial Results on May 11, 2021 April 27, 2021
Sientra Reports Fourth Quarter and Full Year 2020 Financial Results March 11, 2021
Sientra Announces Departure of CFO and Appointment of Interim CFO March 11, 2021
Sientra to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021 February 25, 2021
Sientra to Present at the SVB Leerink 10th Annual Global Healthcare Conference February 11, 2021
Sientra Announces Pricing of Public Offering of Common Stock February 8, 2021
Sientra Commences Public Offering of Common Stock February 8, 2021
Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results February 4, 2021

Nasdaq: SIEN

Stock Quote: NASD

$4.12 -0.27
Volume 482,105
Previous Close 4.38
Intraday High 4.30
Intraday Low 3.94
Pricing delayed 20 minutes
Price Change % Change -6.05% 52 Week High 9.14 52 Week Low 3.80 Today's Open 4.22 Nov 26, 2021 01:00 PM

Email Alerts

Email: *
Subscription Preferences *




 
Enter the code shown above.

Investor Contact

Sientra Investor Relations
805-679-8885

© 2021 Sientra, Inc. All rights reserved.